Pregabalin Treatment for Trigger Points

• Status: Completed
• Trial end date: 2015-01-26
• Target enrollment: 0
• Participant gender: Female

Summary

Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fatih Sultan Mehmet Training and Research Hospital
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Patients who diagnosed fibromyalgia syndrome,

• Patients who were also diagnosed as cervical myofascial pain syndrome based on the upper trapezius muscle

Exclusion Criteria:

• Patients who had received dry needling or local anesthetic injection to trigger point in the dominant upper trapezius muscle within 3 months of the start of the study.

• renal insufficiency,

• impaired liver function,

• malignancy,

• pregnancy

• infections,

• history of drug or alcohol abuse